Labetalol Hydrochloride 5 mg / mL Injection 4 mL
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 00409-2339-34 |
|---|---|
| Product NDC | 00409-2339 |
| Generic Drug Name | Labetalol Hydrochloride |
| Brand Name | Labetalol Hydrochloride |
| Manufacturer | Hospira, Inc. |
| Strength | 5 mg / mL |
| Dosage Form | Injection |
| Drug Type | Intravenous |
| Package Quantity | 10 Carton |
| Package Description | 10 CARTON in 1 PACKAGE (0409-2339-34) / 1 CARTRIDGE in 1 CARTON / 4 mL in 1 CARTRIDGE (0409-2339-24) |
| Active Ingredients | Labetalol Hydrochloride |
| Marketing Category | ANDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
Labetalol Hydrochloride 5 mg / mL Injection is tracked under NDC 00409-2339-34 and rolls up into product family 00409-2339. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.
- Package configuration: 10 Carton.
- Manufacturer: Hospira, Inc..
- Dosage form: Injection.
- Family size: 1 indexed presentation.
Click a tag to refine the catalog view around this product reference.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Potential alternatives with matching presentation
Open the comparison hub or review package-level listings from 2 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.
View Potential Alternative HubLabetalol Hydrochloride 5 mg / mL Injection 4 mL Cartridge2 package-level listings in the comparison hub.Sample package-level pages in this comparison set
Drug Shortage Information
Documented shortage history shows this NDC appeared in shortage records in 2010, 2017, and 2022, suggesting elevated future supply risk due to recurrence.
Drug Shortage Index family
View Labetalol hydrochloride in the Drug Shortage IndexCompare related NDC-level product references and family-level shortage context for Labetalol hydrochloride.This section is intended to help healthcare teams review public shortage history and related availability references for this product. Supply conditions can change quickly across manufacturers, distributors, and care settings, and these references may not reflect the latest market status. Premium Rx National does not guarantee completeness or suitability for clinical, operational, or purchasing decisions. Please confirm current availability with FDA, manufacturers, and other authoritative sources before relying on this information.
Labetalol Hydrochloride 5 mg / mL Injection 4 mL, NDC 00409-2339-34, is a Hospira, Inc. 5 mg / mL injection presentation packaged as 10 Carton. Current public shortage information is available for this product reference.
NDC search formats
- Canonical NDC 11: 00409-2339-34
- Digits-only NDC 11: 00409233934
- Possible 10-digit display format: 0409-2339-34 (0409233934)
Helpful product links
- Search by brand name: Labetalol Hydrochloride
- NDC 11: 00409-2339-34
- Product family NDC: 00409-2339
- VA classification code: CV100
- VA classification code description: BETA BLOCKERS/RELATED
- CMOP ID: L0565
- VUID: 4032011
- UNSPSC code: 51262410
- Misc. Order Numbers: 1010654